Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period ending November 22, 2021. The company is a foreign private issuer based in Israel, focusing on colorectal screening technology.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of other information rather than a financial statement.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing discloses the publication of a peer-reviewed article regarding the company's C-Scan® colorectal screening test, highlighting safety and patient satisfaction data.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Management commentary is limited to the announcement of the peer-reviewed article publication attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the full text of the peer-reviewed article attached as Exhibit 99.1 to assess the clinical significance of the C-Scan® data.
- Confirm the company's current ticker symbol and corporate name status, as the metadata lists "Mbody AI Ltd." while the filing header lists "Check-Cap Ltd."
- Review subsequent filings for financial performance data, as this 6-K contains no quantitative financial metrics.